NCT04798014View on ClinicalTrials.gov

HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy

CompletedOBSERVATIONAL
Enrollment

860

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

August 15, 2023

Study Completion Date

August 15, 2023

Conditions
Cystic Fibrosis
Trial Locations (1)

46202

Indiana University School of Medicine, Indianapolis

Sponsors

Collaborators (1)

Folia Health
All Listed Sponsors
collaborator

Folia Health

INDUSTRY

collaborator

Cystic Fibrosis Foundation

OTHER

lead

Indiana University

OTHER

NCT04798014 - HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy | Biotech Hunter | Biotech Hunter